236 related articles for article (PubMed ID: 37424789)
1. SpyTag/SpyCatcher display of influenza M2e peptide on norovirus-like particle provides stronger immunization than direct genetic fusion.
Lampinen V; Gröhn S; Soppela S; Blazevic V; Hytönen VP; Hankaniemi MM
Front Cell Infect Microbiol; 2023; 13():1216364. PubMed ID: 37424789
[TBL] [Abstract][Full Text] [Related]
2. Antigenicity and immunogenicity of HA2 and M2e influenza virus antigens conjugated to norovirus-like, VP1 capsid-based particles by the SpyTag/SpyCatcher technology.
Heinimäki S; Lampinen V; Tamminen K; Hankaniemi MM; Malm M; Hytönen VP; Blazevic V
Virology; 2022 Jan; 566():89-97. PubMed ID: 34894525
[TBL] [Abstract][Full Text] [Related]
3. Modular vaccine platform based on the norovirus-like particle.
Lampinen V; Heinimäki S; Laitinen OH; Pesu M; Hankaniemi MM; Blazevic V; Hytönen VP
J Nanobiotechnology; 2021 Jan; 19(1):25. PubMed ID: 33468139
[TBL] [Abstract][Full Text] [Related]
4. Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses.
Janitzek CM; Matondo S; Thrane S; Nielsen MA; Kavishe R; Mwakalinga SB; Theander TG; Salanti A; Sander AF
Malar J; 2016 Nov; 15(1):545. PubMed ID: 27825348
[TBL] [Abstract][Full Text] [Related]
5. The position of Spy Tag/Catcher system in hepatitis B core protein particles affects the immunogenicity and stability of the synthetic vaccine.
Sheng Y; Li Z; Lin X; Ma Y; Ren Y; Su Z; Ma G; Zhang S
Vaccine; 2023 Jul; 41(33):4867-4878. PubMed ID: 37391312
[TBL] [Abstract][Full Text] [Related]
6. Bacterial superglue enables easy development of efficient virus-like particle based vaccines.
Thrane S; Janitzek CM; Matondo S; Resende M; Gustavsson T; de Jongh WA; Clemmensen S; Roeffen W; van de Vegte-Bolmer M; van Gemert GJ; Sauerwein R; Schiller JT; Nielsen MA; Theander TG; Salanti A; Sander AF
J Nanobiotechnology; 2016 Apr; 14():30. PubMed ID: 27117585
[TBL] [Abstract][Full Text] [Related]
7. In situ bio-mineralized Mn nanoadjuvant enhances anti-influenza immunity of recombinant virus-like particle vaccines.
Sheng Y; Li Z; Lin X; Wang L; Zhu H; Su Z; Zhang S
J Control Release; 2024 Apr; 368():275-289. PubMed ID: 38382812
[TBL] [Abstract][Full Text] [Related]
8. Display of Streptococcus iniae α-Enolase on the Surface of Virus-Like Particles (VLPs) of Nervous Necrosis Virus (NNV) Using SpyTag/SpyCatcher.
Yang JI; Kim KH
Mar Biotechnol (NY); 2022 Dec; 24(6):1066-1072. PubMed ID: 36171522
[TBL] [Abstract][Full Text] [Related]
9. Improvement of Modular Protein Display Efficiency in SpyTag-Implemented Norovirus-like Particles.
Boonyakida J; Khoris IM; Nasrin F; Park EY
Biomacromolecules; 2023 Jan; 24(1):308-318. PubMed ID: 36475654
[TBL] [Abstract][Full Text] [Related]
10. Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection.
Kim MC; Lee JS; Kwon YM; O E; Lee YJ; Choi JG; Wang BZ; Compans RW; Kang SM
Antiviral Res; 2013 Sep; 99(3):328-35. PubMed ID: 23811283
[TBL] [Abstract][Full Text] [Related]
11. Flagellin/Virus-like Particle Hybrid Platform with High Immunogenicity, Safety, and Versatility for Vaccine Development.
Zhao Y; Li Z; Voyer J; Li Y; Chen X
ACS Appl Mater Interfaces; 2022 May; 14(19):21872-21885. PubMed ID: 35467839
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell activation by a micro particulate based system containing the influenza matrix-2 protein virus-like particle (M2e VLP).
Gomes KB; Allotey-Babington GL; D'Sa S; Kang SM; D'Souza MJ
Int J Pharm; 2022 Jun; 622():121667. PubMed ID: 35304243
[TBL] [Abstract][Full Text] [Related]
13. Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats.
Wang W; Huang B; Wang X; Tan W; Ruan L
Virol Sin; 2019 Oct; 34(5):583-591. PubMed ID: 31240620
[TBL] [Abstract][Full Text] [Related]
14. Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization.
Brune KD; Leneghan DB; Brian IJ; Ishizuka AS; Bachmann MF; Draper SJ; Biswas S; Howarth M
Sci Rep; 2016 Jan; 6():19234. PubMed ID: 26781591
[TBL] [Abstract][Full Text] [Related]
15. Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine.
Carignan D; Thérien A; Rioux G; Paquet G; Gagné ML; Bolduc M; Savard P; Leclerc D
Vaccine; 2015 Dec; 33(51):7245-7253. PubMed ID: 26549362
[TBL] [Abstract][Full Text] [Related]
16. A biomimetic VLP influenza vaccine with interior NP/exterior M2e antigens constructed through a temperature shift-based encapsulation strategy.
Wei J; Li Z; Yang Y; Ma X; An W; Ma G; Su Z; Zhang S
Vaccine; 2020 Aug; 38(38):5987-5996. PubMed ID: 32713681
[TBL] [Abstract][Full Text] [Related]
17. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
Tsybalova LM; Stepanova LA; Kuprianov VV; Blokhina EA; Potapchuk MV; Korotkov AV; Gorshkov AN; Kasyanenko MA; Ravin NV; Kiselev OI
Vaccine; 2015 Jun; 33(29):3398-406. PubMed ID: 25976545
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
19. Bacteriophage T4 Vaccine Platform for Next-Generation Influenza Vaccine Development.
Li M; Guo P; Chen C; Feng H; Zhang W; Gu C; Wen G; Rao VB; Tao P
Front Immunol; 2021; 12():745625. PubMed ID: 34712234
[TBL] [Abstract][Full Text] [Related]
20. A candidate dual vaccine against influenza and noroviruses.
Xia M; Tan M; Wei C; Zhong W; Wang L; McNeal M; Jiang X
Vaccine; 2011 Oct; 29(44):7670-7. PubMed ID: 21839795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
